Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Atara Biotherapeutics, Inc. for potential violations of securities laws
Portfolio Pulse from
Wolf Haldenstein Adler Freeman & Herz LLP is investigating Atara Biotherapeutics, Inc. for potential securities law violations. The investigation focuses on possible securities fraud by the company and its officers or directors.
February 14, 2025 | 1:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Atara Biotherapeutics is under investigation by Wolf Haldenstein for potential securities law violations, focusing on possible fraud by the company and its leadership.
The investigation by a prominent law firm into potential securities fraud is likely to negatively impact Atara's stock price in the short term due to increased legal risks and potential reputational damage.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100